.png){kind=logo}
31%OFF
Stock image for illustration purposes only - book cover, edition or condition may vary.
Tuberculosis & Multidrug-Resistant Tuberculosis: Epidemiology, Diagnosis, Resistance Mechanisms, Treatment Strategies & Novel Drugs
Ahman S.
€ 147.43
€ 101.89
FREE Delivery in Ireland
Description for Tuberculosis & Multidrug-Resistant Tuberculosis: Epidemiology, Diagnosis, Resistance Mechanisms, Treatment Strategies & Novel Drugs
Hardback. Editor(s): Ahmad, Suhail; Mokaddas, Eiman. Num Pages: 121 pages. BIC Classification: MJCJ; MJL. Category: (P) Professional & Vocational. Dimension: 228 x 159 x 15. Weight in Grams: 332.
Tuberculosis (TB), causing nine million active disease cases and 1.5 million deaths every year, is a formidable public health challenge, particularly in poor and developing countries around the world. Major reasons for global burden of TB include association of active disease with human immunodeficiency virus (HIV) coinfection or other underlying immunosuppressive conditions such as diabetes and increasing incidence of drug-resistant, multidrug-resistant (MDR) (resistant at least to rifampicin and isoniazid) and extensively drug-resistant (XDR) (additionally resistant to a fluoroquinolone plus kanamycin/amikacin/capreomycin) strains of M. tuberculosis. While treatment of drug-susceptible TB is effective in >95 percent of disease cases, supervised therapy for ... Read more
Tuberculosis (TB), causing nine million active disease cases and 1.5 million deaths every year, is a formidable public health challenge, particularly in poor and developing countries around the world. Major reasons for global burden of TB include association of active disease with human immunodeficiency virus (HIV) coinfection or other underlying immunosuppressive conditions such as diabetes and increasing incidence of drug-resistant, multidrug-resistant (MDR) (resistant at least to rifampicin and isoniazid) and extensively drug-resistant (XDR) (additionally resistant to a fluoroquinolone plus kanamycin/amikacin/capreomycin) strains of M. tuberculosis. While treatment of drug-susceptible TB is effective in >95 percent of disease cases, supervised therapy for ... Read more
Product Details
Publisher
Nova Science Publishers Inc
Number of pages
121
Format
Hardback
Publication date
2013
Condition
New
Number of Pages
121
Place of Publication
New York, United States
ISBN
9781628083095
SKU
V9781628083095
Shipping Time
Usually ships in 5 to 9 working days
Ref
99-2
Reviews for Tuberculosis & Multidrug-Resistant Tuberculosis: Epidemiology, Diagnosis, Resistance Mechanisms, Treatment Strategies & Novel Drugs